THERAPEUTIC POLYPEPTIDES, HOMOLOGUES THEREOF, FRAGMENTS THEREOF AND APPLICATION THEREOF FOR MODULATION OF PLATELET-MEDIATED AGGREGATION Russian patent published in 2014 - IPC C07K19/00 C07K16/36 C07K16/18 C12N15/13 A61K39/395 A61P7/02 

Abstract RU 2524129 C2

FIELD: medicine.

SUBSTANCE: claimed invention relates to biotechnology and represents a polypeptide construction for treatment, prevention and relief of disorders, associated with an adhesion of platelets and platelet-mediated aggregation or its dysfunction, which includes one or more single-domain antibodies, aimed against the von Willebrand factor (vWF), and one or more single-domain antibodies aimed against serum albumen (SA). The invention also relates to nucleic acid, coding such polypeptide construction, to compositions, containing the said construction, and to its application for obtaining medications for prevention, treatment and relief of the said disorders.

EFFECT: claimed invention makes it possible to extend an assortment of medications for treatment, prevention and relief of disorders, associated with the platelet adhesion and platelet-associated aggregation or its dysfunction.

15 cl, 30 dwg, 32 tbl, 69 ex

Similar patents RU2524129C2

Title Year Author Number
THERAPEUTICAL POLYPEPTIDES, THEIR HOMOLOGS, FRAGMENTS, AND APPLICATION IN THROMBOCYTE-MEDIATED AGGREGATION MODULATION 2004
  • Silans Karen
RU2357974C2
SINGLE-DOMAIN ANTIBODIES DIRECTED AGAINST TUMOUR NECROSIS FACTOR ALPHA, AND USE THEREOF 2012
  • Silans Karen
  • Loverejs Mark
  • De Khard Khans
RU2704232C2
ISOLATED GLYCOPROTEIN IB ALPHA POLYPEPTIDE OF HUMAN THROMBOCYTES, FUSED PROTEIN, DNA MOLECULE (VERSIONS), EXPRESSION VECTOR (VERSIONS), CELL (VERSIONS), POLYPEPTIDE EXPRESSION METHOD, FUSED PROTEIN EXPRESSION METHOD, PHARMACEUTICAL COMPOSITION (VERSIONS), METHOD OF INHIBITING BODING OF BLOOD CELLS TO BIOLOGICAL TISSUE IN BIOLOGICAL SYSTEM, METHOD OF INHIBITING BONDING OF PROTEIN TO BIOLOGICAL TISSUE IN BIOLOGICAL SYSTEM AND DISORDER TREATMENT METHOD 2004
  • Sho Grej
  • Sako Dajann S.
  • Kumar Ravindra
  • Sjuj Tszin'
RU2403262C2
INHIBITORS FOR USING IN HEMOSTASIS AND IMMUNE FUNCTION 2000
  • Sheppard Pol O.
  • Lehsser Dzherald U.
  • Bishop Pol D.
RU2239449C2
METHODS OF TREATING TTP WITH IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS AND USES THEREOF 2015
  • Dyubi Kristian
RU2704444C2
PEPTIDE OR PEPTIDE COMPLEX BINDING TO alpha2- INTEGRIN, METHODS FOR PRODUCTION AND USE THEREOF 2011
  • Korvej Karsten
  • Blum Khorst
  • Kameron Beatris
  • Dabdubi Tarik
  • Dekari Stefani
  • Boren Nikolya
  • Papen David
  • Lange Kristian
RU2588668C2
PROTEIN BOUND WITH HUMAN GLYCOPROTEIN, COMPOSITION, PHARMACEUTICAL COMPOSITION, EXPRESSION VECTOR 2016
  • Bilalde Filip
  • Zhanro-Perrus Martine
RU2773819C2
IMPROVED AMINO ACID SEQUENCES AGAINST IL-6R AND POLYPEPTIDES WHICH CONTAIN THEREOF FOR TREATMENT OF IL-6R ASSOCIATED DISEASES AND DISORDERS 2010
  • Bajrnaehrt, Ehl'S, Anna, Ehllis
  • Ververken, Sedrik, Jozef, Neotere
  • Kolkman, Jost, Aleksander
  • Van Roj, Marten
RU2539798C2
COMPOSITION, INHIBITING PLATELET AGGREGATION 2006
  • Josida, Sigeto
  • Sudo, Tosiki
RU2557296C2
POLYPEPTIDE, POSSESSING INHIBITING ACTIVITY WITH RESPECT TO PLATELET AGGREGATION AND/OR INHIBITING ACTIVITY WITH RESPECT TO PLATELET ADHESION, ENCODING IT POLYNUCLEOTIDE, COMPOSITION AND SET, CONTAINING SAID POLYPEPTIDE 2006
  • Josida Sigeto
  • Sudo Tosiki
RU2434941C2

RU 2 524 129 C2

Authors

Silans Karen

Dates

2014-07-27Published

2004-01-09Filed